401 related articles for article (PubMed ID: 3997787)
1. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
Feighner JP; Herbstein J; Damlouji N
J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
[TBL] [Abstract][Full Text] [Related]
2. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
Rosan TA; Mesones HL; Brengio F
Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185
[TBL] [Abstract][Full Text] [Related]
3. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
Kahn D; Silver JM; Opler LA
J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
[TBL] [Abstract][Full Text] [Related]
4. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
Ketter TA; Post RM; Parekh PI; Worthington K
J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
[TBL] [Abstract][Full Text] [Related]
5. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression.
Fawcett J; Kravitz HM; Zajecka JM; Schaff MR
J Clin Psychopharmacol; 1991 Apr; 11(2):127-32. PubMed ID: 2056139
[TBL] [Abstract][Full Text] [Related]
6. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
[TBL] [Abstract][Full Text] [Related]
7. MAOIs in the contemporary treatment of depression.
Thase ME; Trivedi MH; Rush AJ
Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
[TBL] [Abstract][Full Text] [Related]
8. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
[TBL] [Abstract][Full Text] [Related]
9. Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
Thase ME; Frank E; Mallinger AG; Hamer T; Kupfer DJ
J Clin Psychiatry; 1992 Jan; 53(1):5-11. PubMed ID: 1737741
[TBL] [Abstract][Full Text] [Related]
10. Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy.
Ponto LB; Perry PJ; Liskow BI; Seaba HH
Am J Hosp Pharm; 1977 Sep; 34(9):954-61. PubMed ID: 333909
[TBL] [Abstract][Full Text] [Related]
11. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
[TBL] [Abstract][Full Text] [Related]
12. Coadministration of phenelzine and methylphenidate for treatment-resistant depression.
Shelton Clauson A; Elliott ES; Watson BD; Treacy J
Ann Pharmacother; 2004 Mar; 38(3):508. PubMed ID: 14970373
[No Abstract] [Full Text] [Related]
13. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
König F; Wolfersdorf M
Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
[TBL] [Abstract][Full Text] [Related]
14. Differential response patterns to MAO inhibitors and tricyclics.
Nies A
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
[TBL] [Abstract][Full Text] [Related]
15. Phenelzine treatment of melancholia.
McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
[TBL] [Abstract][Full Text] [Related]
16. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors].
von Oefele K; Grohmann R; Hippius H; Rüther E
Nervenarzt; 1988 Feb; 59(2):118-23. PubMed ID: 3362260
[No Abstract] [Full Text] [Related]
17. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
[TBL] [Abstract][Full Text] [Related]
18. Combined use of tricyclic antidepressants and monoamine oxidase inhibitors.
Lader M
J Clin Psychiatry; 1983 Sep; 44(9 Pt 2):20-4. PubMed ID: 6355073
[TBL] [Abstract][Full Text] [Related]
19. An open study of triiodothyronine augmentation of tricyclic antidepressants in inpatients with refractory depression.
Birkenhäger TK; Vegt M; Nolen WA
Pharmacopsychiatry; 1997 Jan; 30(1):23-6. PubMed ID: 9065966
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
Thomas SJ; Shin M; McInnis MG; Bostwick JR
Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
